The Massachusetts Special Commission on Xylazine will hold preliminary meetings Monday and Tuesday, in efforts to study the increasing presence of the dangerous animal sedative in the state’s illicit drug supply.

The special commission, formed under a law signed by the governor in December 2024, is tasked with forming recommendations to “address the public health and safety concerns posed by the proliferation of xylazine as an additive to illicit drugs.”

The commission will host the first meeting of their working group on education and training Monday at 2 p.m., to be held virtually. A second virtual meeting Tuesday at 9 a.m. will feature the commission’s working group on outreach and treatment. Both public meetings are set to go over “background information, preliminary research and inf

See Full Page